Metropolitan Life Insurance Company (MetLife)’s Enzo Biochem, Inc. ENZ Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-14,697	Closed	-$80.5K	–	2501
2018 Q1	$80.5K	Hold	14,697	–	–	﹤0.01%	2386
2017 Q4	$120K	Sell	14,697 -15,772	-52%	-$151K	﹤0.01%	2209
2017 Q3	$319K	Sell	30,469 -1,362	-4%	-$15.1K	﹤0.01%	1997
2017 Q2	$351K	Hold	31,831	–	–	﹤0.01%	1959
2017 Q1	$266K	Sell	31,831 -353	-1%	-$2.49K	﹤0.01%	2081
2016 Q4	$223K	Sell	32,184 -105	-0.3%	-$670	﹤0.01%	2294
2016 Q3	$164K	Sell	32,289 -267	-0.8%	-$1.59K	﹤0.01%	2452
2016 Q2	$194K	Buy	+32,556	New	+$181K	﹤0.01%	2337

Other funds holding ENZ

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ENZ Position: Q2 2018 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Enzo Biochem, Inc. (ENZ) in Q2 2018, closing a stake of 14,697 shares — an estimated $80.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ENZ in Q2 2016 and held it in 8 quarters. The position peaked at $351K in Q2 2017. 97 funds tracked by Wall St. Rank hold ENZ as of Q2 2018.

Metropolitan Life Insurance Company (MetLife) reported no remaining Enzo Biochem, Inc. position as of Q2 2018 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 14,697 Enzo Biochem, Inc. shares in Q2 2018, an estimated $80.5K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Enzo Biochem, Inc. in Q2 2016 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s Enzo Biochem, Inc. position peaked at $351K in Q2 2017.
97 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2018.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2018, filed 15 Aug 2018.